Ongoing and Planned Clinical Trials
Ongoing
RESMAIN – Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)
The pivotal RESMAIN study is a multi-national, multi-center, double-blind, randomized and placebo controlled study to evaluate resminostat for maintenance treatment of patients with advanced stage (Stage IIB‑IVB) Mycosis Fungoides (MF) or Sézary Syndrome (SS) that have achieved disease control with systemic therapy.
| Recruitment status | Active, not recruiting |
| Study phase | Phase II |
| Enrollment | 201 |
| Primary objective |
|
| Key secondary objective |
|
MERKLIN 2 – Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1
The MERKLIN 2 study is a Phase II clinical study evaluating domatinostat in combination with avelumab in patients with advanced MCC whose disease has progressed on anti-PD-(L)1 antibody therapy.
| Recruitment status | Active, not recruiting |
| Study phase | Phase II |
| Enrollment | 21 |
| Primary objective |
|
| Key secondary objective |
|